The investigation of heat shock protein (HSP70) expression change in human brain asterocytoma tumor

Iranian Journal of Cancer Prevention

Volumn 6, Issue SUPPL.1, 2013, Pages

  Pooladi, Mehdi ^a,b   Sobhi, Sara ^c   Abad, Solmaz Khaghani Razi ^a,b   Hashemi, Mehrdad ^b   Moradi, Afshin ^c,d   Zali, Ali Reza ^c   Mousavi, Masoumea ^a   Zali, Hakimeh ^a   Azodi, Mona Zamanian ^a   Rakhshan, Azadeh ^c   Rezaei Tavirani, Mostafa ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asterocytoma; Electrophoresis; HSP70 heat shock proteins; Proteomics

Indexed keywords

HEAT SHOCK PROTEIN 70;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MOLECULAR DIAGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TUMOR CLASSIFICATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84875352108     PISSN: 20082401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Collet B, Guitton N, Saikali S, Avril T, Pineau C, Hamlat A, et al. Differential analysis of Glioblastoma Multiforme proteome by a 2D-DIGE approach. Proteome Science. 2011; 9: 1-16.
2. Fang X, Wang C, Balgley BM, Zhao K, Eang W, He F, et al. Targeted tissue proteomic analysis of human Astrocytomas. Amerrican Chemical Society. 2012; 11: 3937-3946.
3. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary GiIoblastoma. The American Journal of Patobiology. 2007; 170: 1445-1451.
4. Weiss W, Gorg A. High-Resolution Two- Dimensional Electrophoresis. Proteomics methods in molecular biology. 2009; 564: 13-20.
5. Deighton RF, Short DM, Gregor RJ, Gow AJ, Wittle IR, Culloch J. The utility of functional interaction and cluster analysis in CNS Proteomics. Journal of Neuroscience Methods. 2009; 180: 321-329.
6. Xiong G, Xiao H, Lu J, Zhang D, Bi C, Peng L, et al. Differential protein expression in low-grade Astrocytomas and peritumoral human brain tissues. Neural Regeneration Research. 2010; 5: 1915-1920.
7. Seyfried NT, Huysentruyt LC, Atwood JA, Xia Q, Seyfried TN, Orlando R. Up-regulation of NG2 proteoglycan and interferon induced transmembrane proteins 1 and 3 in mouse Astrocytoma: A membrane proteomics approach. NIH Public Access. 2008; 263: 1-15.
8. Chen X, Zang W, Xue F, Shen Z, Zhang Q. Bioinformatics analysis reveals potential candidate drugs for different subtypes of Glioma. Neurol Sci. 2012; 12: 1-3.
9. Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Molecular Cancer. 2007; 6: 1-13.
10. Khalil AA. Biomarker discovery: a proteomics approach for brain cancer profiling. Japanese Cancer Association. 2007; 98: 201-213.
11. Shen G, Liang S, Xu Z, Zhou L, Xiao S, Xia X, et al. Downregulated expression of HSP27 in humanlow-grade Glioma tissues discovered by a quantitative proteomic analysis. Proteome Science. 2010; 8: 1-17.
12. Shirai K, Suzuki Y, Okamoto M, Wakatsuki M, Noda S, Takahashi T, et al. Influence of histological subtype on Survival after Combined Therapy of Surgery and Radiation in WHO grade III Glioma. Journal Radiat Res. 2010; 51: 589-594.
13. Wise S, Karus M, Faissner A. Astrocytes as a source for extracellular matrix molecules and cytokines. Frontiers in Pharmacology. 2012; 3: 1-4.
14. Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant Glioma and Medulloblastoma. Macmillan Ublishers. 2010; 10: 319-331.
15. Quesada A, Prada F A, Aguilera Y, Espinar A, Carmona A, Prada C. Peripapillary Glial cells in the chick retina: a special Glial cell type expressing Astrocyte, radial Glia, Neuron, and Oligodendrocyte markers throughout development. GLIA. 2004; 46: 346-355.
16. Wilde I B, Brack M, Winget J M, Mayor T. Proteomic characterization of aggregating proteins after the inhibition of the ubiquitin proteasome system. American Chemical Society. 2010; 22: A-K.
17. Zhang M, Wan C, Ji B, Zhang Z, Zhu H, Tian N, et al. Proteome alteration of U251 human Astrocytoma cell after inhibiting retinoic acid synthesis. Mol Cell Biochem. 2009; 323: 185-193.
18. Seigneuric R, Mjahed H, Gobbo J, Joly AL, Berthenet K, Shirley S, et al. Heat Shock Proteins as danger signals for cancer detection. Front Oncol. 2011; 10: 3389-3392.
19. Elstner A, Stockhammer F, Nguyen-Dobinsky TN, Nguyen QL, Pilgermann I, Gill A, et al. Identification of diagnostic serum protein profiles in Glioblastoma patients. Journals Neurooncol. 2011; 102: 71-80.
20. Gollapalli K, Ray S, Srivastava R, Renu D, Singh P, Dhali S, et al. Investigation of serum proteome alterations in human Glioblastoma Multiforme. PMIC. 2012; 23: 1-18.
21. Somasundaram K, Nijaguna MB, Kumar D M. Serum proteomics of Glioma: methods and application. Expert Review of Molecular Diagnostics. 2009; 9: 695-707.
22. Carlesson A, Person O, Ingvarsson J, Widegren B, Salford L, Borrebaeck CAK et al. Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in Glioblastoma Multiforme patients. Proteomics Clinical. 2010; 4: 591-602.
23. Ciocca R, Calderwood S. Heat Shock Proteins in cancer: diagnostic, prognostic, predictive and treatment implications. Cell stress chaperones. 2005; 10: 86-103.
24. Sherman M, Multhoff G. Heat Shock Protein in cancer. Cell Stress Chaperones. 2012; 6: 1-5.
25. Hatfield MP, Lovas S. Role of HSP70 in cancer growth and survival. Protein Pept Lett. 2012; 19: 616-624.
26. Ericson C, Mister M. National biobank program workpackage brain proteomics biobanking. 2006; 5: 1-3.
27. Sun S, Wong T S, Zhang X Q, Jenny K S P, Lee N P, Day P J R, et al. Protein alterations associated with Temozolomide resistance in subclones of human glioblastoma cell lines. Journal Nenrooncol. 2012; 107: 89-100.
28. Vogel T W, Zhuang Z, Li J, Okamoto H, Furuta M, Lee Y S, et al. Proteins and protein pattern differences between Glioma Cell lines and Glioblastoma Multiforme. American Association for Cancer Research Journals. 2011; 11: 3624-3630.